Author

Pricilla Brun

Sanofi (France)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:non-human primate· 1

Frequent Co-Authors

Dimitry OfengeimiD· 1 shared Ross C. GruberiD· 1 shared Timothy J. TurneriD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Dimitry OfengeimORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Comparative CNS Pharmacology of the Brutons Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis.

Timothy J. Turner, Pricilla Brun, Ross C. Gruber, Dimitry Ofengeim

This paper compares the CNS pharmacology of three BTK inhibitors in non-human primates, finding that tolebrutinib achieves higher CSF exposure than the others.

Drugs in R&D · Jun 1, 2024Peer-reviewedPharmacology & Toxicology